Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZEUS Scientific is a commercial-stage company specializing in the development and manufacture of in vitro diagnostic assays for autoimmune and infectious diseases. Their product line includes approximately 150 assays across multiple platforms. The company has a strong track record of regulatory clearances with over 100 IVD products cleared by the FDA. In October 2022, ZEUS Scientific was acquired by Sebia to expand Sebia’s portfolio in autoimmunity diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZEUS Scientific.